Source: International Congress 2014 – New and old players in fibrotic lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Mueller, S. Cicko, M. Idzko (Aachen, Freiburg, Germany). Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis. Eur Respir J 2014; 44: Suppl. 58, 3907

Member's Comments

No comment yet.

Related content which might interest you: CD39 deficiency results in increased inflammation in an animal model of pulmonary fibrosis Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Resveratrol regulates ECM remodeling in lung fibrosis Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Matriptase triggers pleiotropic functional responses in normal human lung fibroblasts (NHLF): Potential relevance in pathophysiology Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 Regulation of WISP1 by profibrotic cytokines in pulmonary fibrosis Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells Year: 2014 Comparison of reducing effect on lung injury of dexamethasone and bosentan in acute lung injury: An experimental study Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 The role of 5-HT2 receptors in the early development of lung fibrosis Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells Year: 2014 Injury and repair responses of parenchymal fibroblasts in advanced chronic obstructive pulmonary disease Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more Year: 2014 Inhaled silver nanoparticles induce pulmonary oxidative injury and inflammation: Differential effects between rat strains Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 The effect of dasatinib, a novel tyrosine kinase inhibitor, on the regression of pulmonary fibrosis in mice Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Sulforaphane attenuates lung fibrosis in bleomycin-induced pulmonary fibrosis via inhibition of TGF-beta/Smad signaling Source: International Congress 2014 – ILDs 4 Year: 2014 Neurogenic pulmonary edema: Effect of corticosteroids Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 Proteasome function in pulmonary fibrosis Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells Year: 2014 Neutrophil elastase inhibitor sivelestat ameliorates gefitinib-induced acute pneumonitis in mice Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 LATE-BREAKING ABSTRACT: The effects and mechanism of adiponectin on inhibiting pulmonary fibrosis Source: International Congress 2014 – ILDs 1 Year: 2014 Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Effect of pirfenidone on IPF progression Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Protective effects of Dengzhanshengmai capsules on bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2014 – ILDs 3 Year: 2014 Inhibition of profibrotic signaling in fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) by histone deacetylase-inhibitors (HDACi) or the IPF drug pirfenidone Source: International Congress 2014 – ILDs 1 Year: 2014 Metalloproteases gene expression and remodeling of lung parenchyma fibers during the progression of elastase induced emphysema Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Pirfenidone and BIBF1120 regulate properties of myofibroblasts Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014